Objectives. To determine the incidence of non-Hodgkin's lymphoma (NHL) and
renal cell carcinoma (RCC) after a diagnosis of the other malignancy.
Methods. The 1973 to 1994 Surveillance, Epidemiology, and End Results (SEER
) data base was used to determine the age-, sex-, race-, and calendar year-
specific incidence rates for each year for RCC and NHL. The expected number
of second cancers for each sex, race, and follow-up period (less than 1, 1
to 5, 5 to 10, and 10 or more years) was obtained by multiplying these inc
idence rates by the age-, sex-, race-, and calendar year-specific number of
person-years at risk, with these products summed over the different age gr
oups and calendar years. The standardized incidence ratio (SIR) was calcula
ted (observed/expected number of second cancers), with statistical signific
ance determined using the Poisson test.
Results. From 1973 to 1994, 32,293 individuals in the SEER data base were d
iagnosed with RCC and 63,997 with NHL. NHL was diagnosed after RCC in 67 ca
ses versus 59.8 expected (SIR 1.12, P = 0.19) and RCC after NHL in 96 cases
versus 56.1 expected (SIR 1.71, P <0.0001). Only white males and females h
ad a significantly increased risk of RCC after NHL, which was limited to th
e first year of follow-up. Excluding the first year of follow-up, NHL was d
iagnosed after RCC in 54 cases versus 49.3 expected (SIR 1.10, P = 0.27) an
d RCC after NHL in 54 cases versus 45.1 expected (SIR 1.20, P = 0.11).
Conclusions. When the first year of follow-up is excluded, there is no incr
eased risk of NHL after RCC or vice versa. UROLOGY 54: 28-33, 1999. (C) 199
9, Elsevier Science Inc.